BML Capital Management
Latest statistics and disclosures from BML Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ACRS, AVIR, ENGN, KHC, OM, and represent 73.32% of BML Capital Management's stock portfolio.
- Added to shares of these 8 stocks: ENGN (+$12M), KHC (+$8.0M), OM, KMX, CNTB, CORZ, TSLA, PMVP.
- Started 3 new stock positions in TSLA, CORZ, ENGN.
- Reduced shares in these 4 stocks: ACRS (-$12M), ORMP (-$11M), Kezar Life Sciences (-$5.3M), AVIR.
- Sold out of its position in Kezar Life Sciences.
- BML Capital Management was a net seller of stock by $-4.8M.
- BML Capital Management has $176M in assets under management (AUM), dropping by 13.02%.
- Central Index Key (CIK): 0001616824
Tip: Access up to 7 years of quarterly data
Positions held by BML Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for BML Capital Management
BML Capital Management holds 18 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Aclaris Therapeutics (ACRS) | 36.0 | $63M | -15% | 12M | 5.29 |
|
| Atea Pharmaceuticals (AVIR) | 18.4 | $32M | 7.0M | 4.65 |
|
|
| Engene Therapeutics Com *a* (ENGN) | 6.6 | $12M | NEW | 6.7M | 1.73 |
|
| Kraft Heinz (KHC) | 6.2 | $11M | +272% | 465k | 23.62 |
|
| Outset Med Com New (OM) | 6.2 | $11M | +32% | 2.5M | 4.32 |
|
| CarMax (KMX) | 5.2 | $9.1M | +11% | 173k | 52.89 |
|
| Tillys Cl A (TLYS) | 5.1 | $9.0M | 2.2M | 4.20 |
|
|
| Pmv Pharmaceuticals (PMVP) | 4.1 | $7.1M | 5.3M | 1.34 |
|
|
| Instil Bio Com New (TIL) | 2.8 | $5.0M | 646k | 7.69 |
|
|
| Target Corporation (TGT) | 2.8 | $4.9M | 38k | 130.61 |
|
|
| Oramed Pharmaceuticals Com New (ORMP) | 2.4 | $4.2M | -72% | 866k | 4.81 |
|
| Janux Therapeutics (JANX) | 1.4 | $2.4M | 155k | 15.36 |
|
|
| Pliant Therapeutics (PLRX) | 1.0 | $1.8M | 1.5M | 1.14 |
|
|
| Connect Biopharma Hldgs SHS (CNTB) | 0.8 | $1.4M | +40% | 573k | 2.38 |
|
| Imagenebio (IMA) | 0.7 | $1.2M | 201k | 5.90 |
|
|
| Wal-Mart Stores Put Option (WMT) | 0.2 | $386k | 335.00 | 1152.50 |
|
|
| Core Scientific Put Option (CORZ) | 0.2 | $298k | NEW | 800.00 | 372.50 |
|
| Tesla Motors Put Option (TSLA) | 0.2 | $270k | NEW | 375.00 | 720.00 |
|
Past Filings by BML Capital Management
SEC 13F filings are viewable for BML Capital Management going back to 2022
- BML Capital Management 2026 Q2 filed Aug. 7, 2026
- BML Capital Management 2026 Q1 filed May 6, 2026
- BML Capital Management 2025 Q4 filed Feb. 3, 2026
- BML Capital Management 2025 Q3 filed Nov. 10, 2025
- BML Capital Management 2025 Q2 filed Aug. 11, 2025
- BML Capital Management 2025 Q1 filed May 7, 2025
- BML Capital Management 2024 Q4 filed Feb. 7, 2025
- BML Capital Management 2024 Q3 filed Nov. 5, 2024
- BML Capital Management 2024 Q2 filed Aug. 7, 2024
- BML Capital Management 2024 Q1 restated filed April 24, 2024
- BML Capital Management 2024 Q1 filed April 23, 2024
- BML Capital Management 2023 Q4 restated filed Feb. 2, 2024
- BML Capital Management 2023 Q4 filed Jan. 30, 2024
- BML Capital Management 2023 Q3 filed Oct. 23, 2023
- BML Capital Management 2023 Q2 filed July 24, 2023
- BML Capital Management 2023 Q1 filed April 14, 2023